These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9539885)

  • 1. Within trial variation--a false trail?
    Altman DG
    J Clin Epidemiol; 1998 Apr; 51(4):301-3. PubMed ID: 9539885
    [No Abstract]   [Full Text] [Related]  

  • 2. On reaching the tunnel at the end of the light.
    Horwitz RI; Singer BH; Makuch RW; Viscoli CM
    J Clin Epidemiol; 1997 Jul; 50(7):753-5. PubMed ID: 9253384
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous testing strategy for comparing two treatments in a stratified binomial trial.
    Railkar RA; Mehrotra DV; Iglewicz B
    J Biopharm Stat; 2000 Aug; 10(3):335-49. PubMed ID: 10959915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMMIT/CCS-2 studies.
    Garton M
    Lancet; 2006 Aug; 368(9536):642; author reply 642-3. PubMed ID: 16920459
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 6. Factorial trials in cardiology: pros and cons.
    Lubsen J; Pocock SJ
    Eur Heart J; 1994 May; 15(5):585-8. PubMed ID: 8055995
    [No Abstract]   [Full Text] [Related]  

  • 7. Is an additional post-myocardial infarction beta-blocker trial required in the era of early revascularization?
    Mickley H; Eiskjaer H; Bøtker HE
    Eur Heart J; 2004 Jan; 25(1):96-7. PubMed ID: 14683749
    [No Abstract]   [Full Text] [Related]  

  • 8. On wisdom after the event.
    Senn S; Harrell F
    J Clin Epidemiol; 1997 Jul; 50(7):749-51. PubMed ID: 9253383
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefit of beta-blockers after myocardial infarction.
    Owen A
    Lancet; 2001 Oct; 358(9291):1457-8. PubMed ID: 11705520
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.
    Yusuf S; Wittes J; Probstfield J
    Am J Cardiol; 1990 Jul; 66(2):220-2. PubMed ID: 1973589
    [No Abstract]   [Full Text] [Related]  

  • 11. Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses.
    Smith GD; Egger M
    J Clin Epidemiol; 1998 Apr; 51(4):289-95. PubMed ID: 9539883
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Something old, something new: beta blockers and clopidogrel in acute myocardial infarction.
    Sabatine MS
    Lancet; 2005 Nov; 366(9497):1587-9. PubMed ID: 16271628
    [No Abstract]   [Full Text] [Related]  

  • 14. Carvedilol following AMI.
    Herner SJ; Seaton TL
    J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta-blocker in secondary prevention of cardiovascular disease].
    Sauer G
    Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
    Dargie HJ
    Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical decision making using cumulative meta-analysis.
    Conti CR
    Clin Cardiol; 1993 Mar; 16(3):167-8. PubMed ID: 8095197
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel and metoprolol in myocardial infarction.
    Borja J; García O; Donado E; Izquierdo I
    Lancet; 2006 Mar; 367(9513):811-2. PubMed ID: 16530566
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.
    Zhao L; Tian L; Claggett B; Pfeffer M; Kim DH; Solomon S; Wei LJ
    JAMA Cardiol; 2018 Apr; 3(4):357-358. PubMed ID: 29541747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
    Avezum A; Pais P; Flather MD; Anand S; Yusuf S
    Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.